-DOCSTART- -X- O
Several -X- _ O
studies -X- _ O
have -X- _ O
shown -X- _ O
a -X- _ O
reduced -X- _ O
efficacy -X- _ O
of -X- _ O
influenza -X- _ O
vaccines -X- _ O
in -X- _ O
the -X- _ O
elderly -X- _ O
compared -X- _ O
to -X- _ O
young -X- _ O
adults. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
evaluated -X- _ O
the -X- _ O
immunogenicity -X- _ O
and -X- _ O
protective -X- _ O
efficacy -X- _ O
of -X- _ O
a -X- _ O
commercially -X- _ B-Intervention
available -X- _ I-Intervention
inactivated -X- _ I-Intervention
influenza -X- _ I-Intervention
vaccine -X- _ I-Intervention
( -X- _ I-Intervention
Fluzone -X- _ I-Intervention
( -X- _ I-Intervention
® -X- _ I-Intervention
) -X- _ I-Intervention
) -X- _ I-Intervention
in -X- _ O
young -X- _ B-Patient
adult -X- _ I-Patient
and -X- _ I-Patient
aged -X- _ I-Patient
mice. -X- _ I-Patient
C57 -X- _ I-Patient
/ -X- _ I-Patient
BL6 -X- _ I-Patient
mice -X- _ I-Patient
were -X- _ O
administered -X- _ O
a -X- _ O
single -X- _ B-Intervention
or -X- _ I-Intervention
double -X- _ I-Intervention
immunization -X- _ I-Intervention
of -X- _ I-Intervention
Fluzone -X- _ I-Intervention
( -X- _ I-Intervention
® -X- _ I-Intervention
) -X- _ I-Intervention
with -X- _ I-Intervention
or -X- _ I-Intervention
without -X- _ I-Intervention
CpG -X- _ I-Intervention
and -X- _ I-Intervention
challenged -X- _ I-Intervention
intranasally -X- _ I-Intervention
with -X- _ I-Intervention
H1N1 -X- _ I-Intervention
A -X- _ I-Intervention
/ -X- _ I-Intervention
California -X- _ I-Intervention
/ -X- _ I-Intervention
09 -X- _ I-Intervention
virus. -X- _ I-Intervention
A -X- _ O
double -X- _ B-Outcome
immunization -X- _ I-Outcome
of -X- _ I-Outcome
Fluzone -X- _ I-Outcome
( -X- _ I-Outcome
® -X- _ I-Outcome
) -X- _ I-Outcome
adjuvanted -X- _ I-Outcome
with -X- _ I-Outcome
CpG -X- _ I-Outcome
elicited -X- _ I-Outcome
the -X- _ I-Outcome
highest -X- _ I-Outcome
level -X- _ I-Outcome
of -X- _ I-Outcome
protection -X- _ I-Outcome
in -X- _ I-Outcome
young -X- _ I-Outcome
adult -X- _ I-Outcome
mice -X- _ I-Outcome
which -X- _ I-Outcome
was -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
increases -X- _ I-Outcome
in -X- _ I-Outcome
influenza -X- _ I-Outcome
specific -X- _ I-Outcome
IgG -X- _ I-Outcome
, -X- _ I-Outcome
elevated -X- _ I-Outcome
HAI -X- _ I-Outcome
titres -X- _ I-Outcome
, -X- _ I-Outcome
reduced -X- _ I-Outcome
viral -X- _ I-Outcome
titres -X- _ I-Outcome
and -X- _ I-Outcome
lung -X- _ I-Outcome
inflammation. -X- _ I-Outcome
In -X- _ I-Outcome
contrast -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
vaccine -X- _ I-Outcome
schedule -X- _ I-Outcome
which -X- _ I-Outcome
provided -X- _ I-Outcome
fully -X- _ I-Outcome
protective -X- _ I-Outcome
immunity -X- _ I-Outcome
in -X- _ I-Outcome
young -X- _ I-Outcome
adult -X- _ I-Outcome
mice -X- _ I-Outcome
conferred -X- _ I-Outcome
limited -X- _ I-Outcome
protection -X- _ I-Outcome
in -X- _ I-Outcome
aged -X- _ I-Outcome
mice. -X- _ I-Outcome
Antigen -X- _ I-Outcome
presenting -X- _ I-Outcome
cells -X- _ I-Outcome
from -X- _ I-Outcome
aged -X- _ I-Outcome
mice -X- _ I-Outcome
were -X- _ I-Outcome
found -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
less -X- _ I-Outcome
responsive -X- _ I-Outcome
to -X- _ I-Outcome
in -X- _ I-Outcome
vitro -X- _ I-Outcome
stimulation -X- _ I-Outcome
by -X- _ I-Outcome
Fluzone -X- _ I-Outcome
and -X- _ I-Outcome
CpG -X- _ I-Outcome
which -X- _ I-Outcome
may -X- _ I-Outcome
partially -X- _ I-Outcome
explain -X- _ I-Outcome
this -X- _ I-Outcome
result. -X- _ I-Outcome
Our -X- _ O
data -X- _ O
are -X- _ O
supportive -X- _ O
of -X- _ O
studies -X- _ O
that -X- _ O
have -X- _ O
shown -X- _ O
limited -X- _ B-Outcome
effectiveness -X- _ I-Outcome
of -X- _ I-Outcome
influenza -X- _ I-Outcome
vaccines -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
elderly -X- _ I-Outcome
and -X- _ O
provide -X- _ O
important -X- _ O
information -X- _ O
relevant -X- _ O
to -X- _ O
the -X- _ O
design -X- _ O
of -X- _ O
more -X- _ O
immunogenic -X- _ O
vaccines -X- _ O
in -X- _ O
this -X- _ O
age -X- _ O
group -X- _ O
. -X- _ O

